Clinical characteristics of Japanese patients with anti-PL-7 (anti-threonyl-tRNA synthetase) autoantibodies

Clinical and Experimental Rheumatology

Volumn 23, Issue 5, 2005, Pages 609-615

  Sato, Shinji ^a   Hirakata, Michito ^a   Kuwana, Masataka ^a   Nakamura, Kunio ^a   Suwa, Akira ^a   Inada, Shinichi ^b   Mimori, Tsuneyo ^c   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti aminoacyl tRNA synthetases (ARS) antibodies; Interstitial lung disease (ILD); Polymyositis dermatomyositis (PM DM)

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; PREDNISOLONE; THREONINE TRANSFER RNA LIGASE;

ADULT; ANTIBODY DETECTION; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BLOOD SAMPLING; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DERMATOMYOSITIS; DIABETES MELLITUS; DISEASE COURSE; DRUG DOSE REGIMEN; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; JAPAN; LUNG FIBROSIS; MALE; MUSCLE BIOPSY; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYOSITIS; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; THREONINE-TRNA LIGASE;

EID: 24944576222     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. HIRAKATA M, MIMORI T, AKIZUKI M, CRAFT J, HARDIN JA, HOMMA M: Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35: 449-56.
2. MATHEWS MB, REICHLIN M, HUGHES GR, BERNSTEIN RM: Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med 1984; 160: 420-34.
3. Ala coexist and are associated with myositis. J Exp Med 1986; 163: 1281-91.
4. TARGOFF IN, ARNETT FC: Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990; 88: 241-51.
5. MIMORI T, HAMA N, SUWA A, HIRAKATA M: Anti-Ku antibody and anti-Jo-1 antibody. Clin Immunol 1990; 22: 1812-20.
6. TARGOFF IN: Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 1990; 144: 1737-43.
7. TARGOFF IN: Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20: 857-80.
8. HIRAKATA M, AKIZUKI M: Anti Jo-1 antibody and other anti aminoacyl t-RNA synthetase antibodies. Medicina 1994; 31: 612-4 (in Japanese).
9. SATOH S, HIRAKATA M, SUWA A, MIMORI T, INADA S, AKIZUKI M: Two cases of interstitial pneumonia with anti-PL-12 (alanyl-tRNA synthetase) antibodies. Ryumachi 1996; 36: 862-8 (in Japanese).
10. HIRAKATA M, SUWA A, NAGAI S et al.: Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999; 162: 2315-20.
11. ARNETT FC, TARGOFF IN, MIMORI T, GOLDSTEIN R, WARNER NB, REVEILLE JD: Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996; 39: 1507-1518.
12. WASKO MC, CARLSON GW, TOMAINO MM, ODDIS CV: Dermatomyositis with erosive arthropathy: association with the anti-PL-7 antibody. J Rheumatol 1999; 26: 2693-4.
13. TARGOFF IN, TRIEU EP, PLOTZ PH, MILLER FW: Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992; 35: 821-30.
14. MARGUERIE C, BUNN CC, BEYNON HL et al.: Polymyositis, pulmonary fibrosis and autoantibodies to aminoalcyl-tRNA synthetase enzymes. Q J Med 1990; 77: 1091-38.
15. TARGOFF IN, ARNETT FC, REICHLIN M: Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988; 31: 515-24.
16. BOHAN A, PETER JB: Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344.
17. LANE RJ, EMSLIE-SMITH A, MOSQUERA IE, HUDGSON P: Clinical, biochemical and histological responses to treatment in polymyositis: a prospective study. J R Soc Med 1989; 82: 333-8.
18. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
19. SATOH M, AJMANI AK, HIRAKATA M, SUWA A, WINFIELD JB, REEVES WH: Onset of polymyositis with autoantibodies to threonyl-tRNA synthetase during pregnancy. J Rheumatol 1994; 21: 1564-6.
20. McHUGH NJ, HARVEY GR, WHYTE J, DORSEY JK: Segregation of autoantibodies with disease in monozygotic twin pairs discordant for systemic sclerosis. Three further cases. Arthritis Rheum 1995; 38: 1845-50.
21. KUWANA M, OKANO Y, KABURAKI J, TOJO T, MEDSGER TA Jr: Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994; 37: 902-6.
22. ODDIS CV, SCIURBA FC, ELMAGD KA, STARZL TE: Tacrolimus in refractory polymyositis with interstitial lung disease. The Lancet 1999; 353: 1762-3.
23. SATOH S, HIRAKATA M, NAKAMURA K et al.: Two cases of polymyositis associated with interstitial pneumonia with anti-OJ (isoleucyl tRNA synthetase) antibodies. Ryumachi 1998; 38: 534-41 (in Japanese).